Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Iridex Corp (NQ: IRIX ) 1.750 -0.040 (-2.23%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Iridex Corp Iridex Reports Second Quarter 2024 Financial Results August 08, 2024 From IRIDEX Corporation Via GlobeNewswire Iridex Announces Convertible Note Financing August 05, 2024 From IRIDEX Corporation Via GlobeNewswire Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024 July 30, 2024 From IRIDEX Corporation Via GlobeNewswire IRIDEX Corp. (NASDAQ: IRIX) Records 52-Week High Tuesday Morning October 31, 2023 Via Investor Brand Network Iridex Reports First Quarter 2024 Financial Results May 14, 2024 From IRIDEX Corporation Via GlobeNewswire Iridex to Report First Quarter 2024 Financial Results on May 14, 2024 May 08, 2024 From IRIDEX Corporation Via GlobeNewswire Iridex Reports Fourth Quarter and Full Year 2023 Financial Results March 26, 2024 Advances strategic review to unlock shareholder value From IRIDEX Corporation Via GlobeNewswire Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024 March 20, 2024 From IRIDEX Corporation Via GlobeNewswire Iridex Corporation Receives European Patent on MicroPulse Technology February 06, 2024 The Advanced Short Pulse Laser System From IRIDEX Corporation Via GlobeNewswire Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust January 24, 2024 From IRIDEX Corporation Via GlobeNewswire Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma January 11, 2024 From IRIDEX Corporation Via GlobeNewswire Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation December 28, 2023 Action Retains Full Patient Access to MicroPulse® Transscleral Laser Treatment From IRIDEX Corporation Via GlobeNewswire Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation November 27, 2023 From IRIDEX Corporation Via GlobeNewswire Iridex Reports Third Quarter 2023 Financial Results and Business Update November 14, 2023 From IRIDEX Corporation Via GlobeNewswire Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023 November 13, 2023 The Company also announced plans to present at Stifel Healthcare Conference From IRIDEX Corporation Via GlobeNewswire Iridex to Report Third Quarter Financial Results on November 14, 2023 October 26, 2023 From IRIDEX Corporation Via GlobeNewswire Iridex Announces Strategic Review to Unlock Shareholder Value August 29, 2023 From IRIDEX Corporation Via GlobeNewswire Iridex Reports Second Quarter 2023 Financial Results August 10, 2023 From IRIDEX Corporation Via GlobeNewswire Iridex to Report Second Quarter Financial Results on August 10, 2023 July 27, 2023 From IRIDEX Corporation Via GlobeNewswire Iridex Reports First Quarter 2023 Financial Results May 11, 2023 From IRIDEX Corporation Via GlobeNewswire Iridex to Report First Quarter Financial Results on May 11, 2023 April 27, 2023 From IRIDEX Corporation Via GlobeNewswire Iridex Reports Fourth Quarter and Full Year 2022 Financial Results March 09, 2023 Achieves Record Quarterly Glaucoma Probe Sales and 6% Full Year Revenue Growth From IRIDEX Corporation Via GlobeNewswire Iridex to Present at the 35th Annual Roth Conference March 07, 2023 From IRIDEX Corporation Via GlobeNewswire Iridex Introduces New Research and Showcases Five Events at the AGS Meeting March 02, 2023 From IRIDEX Corporation Via GlobeNewswire Iridex to Report Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023 February 23, 2023 From IRIDEX Corporation Via GlobeNewswire Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2022 January 10, 2023 Achieves Record Quarterly Glaucoma Probe sales and 6% Full Year Revenue Growth From IRIDEX Corporation Via GlobeNewswire Iridex to Participate in Fireside Chat with Stifel Equity Research December 06, 2022 From IRIDEX Corporation Via GlobeNewswire Iridex Announces Record Third Quarter 2022 Financial Results November 10, 2022 Company Announces FDA Clearance of new Iridex Pascal® Scanning Laser Platform From IRIDEX Corporation Via GlobeNewswire Iridex to Report Third Quarter 2022 Financial Results on November 10, 2022 October 27, 2022 From IRIDEX Corporation Via GlobeNewswire Iridex Showcases its Non-Incisional Treatments for Glaucoma, Introduces Sweep Management Software, and Hosts 8 Physician Presentations at AAO 2022 September 29, 2022 From IRIDEX Corporation Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.